Effect of Antipsychotic Drugs on the Cardiac Function of Patients with Schizophrenia and Analysis of Echocardiogram Results
Download PDF


Antipsychotic drugs
Cardiac function



Submitted : 2023-02-26
Accepted : 2023-03-13
Published : 2023-03-28


Objective: To explore and analyze the effect of antipsychotic drug treatment on the cardiac function of patients with schizophrenia. Methods: From January 2021 to December 2022, 30 patients with schizophrenia were divided into three groups, group A (n = 10), group B (n = 10), and group C (n = 10), by random number table. Patients in group A were treated with risperidone, patients in group B were treated with quetiapine, and patients in group C were treated with aripiprazole. The Positive and Negative Syndrome Scale (PANSS) and Lowenstein Occupational Therapy Cognitive Assessment (LOTCA) scores, electrocardiogram results, and echocardiogram results were compared among the three groups. Results: There were no significant differences in PANSS and LOTCA scores among the three groups after treatment (P > 0.05). Electrocardiogram showed that the incidence of prolonged QT interval in group C was higher than that in groups A and B (P < 0.05); echocardiogram showed that the left ventricular ejection fraction (LVEF) and left ventricular end-diastolic volume (LVEDV) in group C were lower than those in group A and group B (P < 0.05). Conclusion: Risperidone, quetiapine, and aripiprazole can improve the symptoms and cognitive function in patients with schizophrenia. Aripiprazole has a greater impact on cardiac function, as evidenced on electrocardiogram and echocardiogram. Therefore, close monitoring must be done to ensure drug safety.


Xu H, Zhang M, Cao Y, et al., 2019, A Network Meta-Analysis of the Effects of Second-Generation Antipsychotic Drugs on Metabolic Syndrome Related Indicators in Patients with Schizophrenia. Chinese Journal of New Medicine, 31(19): 1952–1961.

Liu S, Zhang L, Gao X, et al., 2022, Research Progress of Abnormal Glucose and Lipid Metabolism Induced by Atypical Antipsychotic Drugs in Patients with Schizophrenia and Its Mechanism. Modern Medicine and Clinic, 37(12): 2911–2916.

Xu X, Fang M, Miao Y, et al., 2012, Effects of Different Antipsychotic Drugs on Cognitive Function, Learning and Memory Ability and Glucose and Lipid Metabolism in MK-801-Induced Schizophrenia Rats. Journal of Chinese People’s Liberation Army Medicine, 34(4): 7–12.

Su JF, Feng X, Zhao YL, et al., 2012, Effect of Antipsychotic Drug Treatment on the Ratio of Neutrophils to Lymphocytes in Peripheral Blood of Patients with Schizophrenia. Journal of Medical College of Shantou University, 35(4): 217–220 + 224.

Yao G, Xie Y, Yi S, 2019, Risk Factors of Electrocardiogram ST-T Changes in Patients with Schizophrenia Treated with Long-Term Antipsychotic Drugs. Journal of Modern Electrophysiology, 29(1): 25–29.

Wang T, Huang D, Xie X, 2022, Application Effect and Safety of Antipsychotic Drugs Combined with Biofeedback Therapy in First-Episode Schizophrenia. Chinese Medicine Innovation, 19(20): 137–140.

Liu X, Cao C, Wang T, et al., 2022, Efficacy Analysis of Improved Electroconvulsive Therapy Combined with Second-Generation Antipsychotic Drugs in the Treatment of Schizophrenia. Zhongnan Medical Science Journal, 50(2): 272–275.

Bu F, Chai J, Bai B, et al., 2022, Meta-Analysis of Electroacupuncture Combined with Antipsychotic Drugs to Reduce PANSS Score in Schizophrenia. Shaanxi Traditional Chinese Medicine, 43(8): 1128–1134.

Zhou J, Zhang F, Liu W, et al., 2022, Cross-Sectional Study on Pulmonary Infection Caused by Second-Generation Antipsychotic Drugs in Inpatients with Schizophrenia. Pharmaceutics and Clinical Research, 30(6): 550–553.

Li L, 2022, Study on the Effect of Non-Convulsive Electric Shock Combined with Antipsychotic Drugs in the Treatment of Refractory Schizophrenia. China Practical Medicine, 17(12): 137–139.

Wen C, Zhao R, Feng L, et al., 2022, Effects of Psychological Intervention, Skill Training Combined with Antipsychotic Drug Treatment on Social Function and Quality of Life in Patients with Schizophrenia. Contemporary Medicine Essays, 20(6): 21–24.

Han X, Cui L, Wei Z, et al., 2019, Effects of Six Atypical Antipsychotic Drugs on Endocrine in Patients with Schizophrenia. Chinese Journal of Gerontology, 39(23): 5752–5754.

Zhao Y, Chen C, 2021, Effects of Different Frequencies of Non-Convulsive Electroshock Combined with Antipsychotic Drugs on Positive and Negative Symptom Scale Scores and Cognitive Function in Inpatients with Schizophrenia. Journal of Clinical and Pathology, 41(4): 764–769.

Guo Y, Lei X, Zeng Y, et al., 2021, Effects of Antipsychotic Drugs on Gray Matter Areas in Adolescents with First-Episode Schizophrenia. Journal of Psychiatry, 34(1): 56–59.

Xie M, Chen J, Zhan J, 2021, Efficacy and Safety of Atypical Antipsychotic Drugs Combined with MECT and R-TMS in the Treatment of First-Episode Schizophrenia. Chinese and Foreign Medical Research, 19(32): 155–157.